A ntigen-presenting cells, such as monocytes and macrophages, are the primary source of interleukin (IL)-12. Importantly, IL-12 induces the polarization of CD4 + T cells to the T helper 1 (Th1) phenotype that mediates immunity against intracellular pathogens.
[1] Acute hyperglycemia influences the innate immune system. [2] IL-12 responses from peripheral blood mononuclear cells (PBMCs) were influenced by glucose and insulin. [3] The IL-12 production in the peripheral blood of high-risk insulin-dependent diabetes mellitus (DM) subjects was increased in vitro. [4] Lipopolysaccharide (LPS)-stimulated PBMCs of type 2 DM patients treated with glucose produced more IL-12. [5] Even though the hyperglycemic PBMCs were additionally treated with insulin, the PBMCs still produced more IL-12 in vitro. 
Glucose Increases Interleukin-12 Gene Expression and Production in Stimulated Peripheral Blood Mononuclear Cells of Type 2 Diabetes Patients

At a Glance Commentary
Scientific background of the subject
Lipopolysaccharide-stimulated peripheral blood mononuclear cells of type 2 diabetes patients treated with glucose produced more interleukin-12. Hyperglycemia also resulted in hyperosmolarity in blood. It is unclear whether the increased interleukin-12 production from diabetes patients with severe sepsis is due to enhanced gene expression or increased osmolarity.
What this study adds to the field
The increase in the glucose-mediated interleukin-12 production in diabetes patients was through an increase in the interleukin-12 gene expression. Hyperosmolarity did not influence interleukin-12 gene expression and production. Glucose might act as an enhancer of the lipopolysaccharide-related increase in IL-12 production.
Furthermore, elevated glucose levels and DM promoted the IL-12 gene expression in mouse macrophages. [6] It is reasonable to hypothesize that human hyperglycemic PBMCs produced more IL-12 through increased IL-12 gene expression.
Hyperglycemia also results in hyperosmolarity in blood. Compared with 5 mmol/l glucose, 15 mmol/l mannitol increased more IL-6 and tumor necrosis factor (TNF)-α production from activated monocytes. [7] Higher osmolarities also resulted in increased secretion of IL-8, IL-6, IL-1β, and TNF-α from epithelial cell lines. [8] Up to now, there is no report showing the association of high osmolarities with IL-12 production from cells.
It is unclear whether the increased IL-12 production is due to enhanced gene expression or increased osmolarity. Thus, we designed an in vitro experimental model to clarify the following: (1) whether glucose or hyperosmolarity affects the IL-12 gene expression in stimulated PBMCs and (2) whether glucose or hyperosmolarity enhances the IL-12 production from stimulated PBMCs.
METHODS
Participants
Between September 2009 and March 2010, 13 type 2 DM patients were enrolled. DM was defined according to the definition of the American Diabetes Association. [9] Clinical data such as chest radiography, and white blood count and differential count were normal in all subjects. None of the subjects had pyuria and abnormal liver function test. For validating data, eight healthy controls with normal fasting blood glucose were enrolled from our healthy evaluation center. All subjects provided written informed consent. This study was approved by the Institutional Review Board at the Chang Gung Memorial Hospital.
PBMCs preparation
Whole blood (20 ml) was obtained from each subject and immediately mixed with heparin at 0900-0950 hours. The PBMCs were isolated via differential centrifugation over Ficoll-Plaque (Amersham Biosciences, Uppsala, Sweden) within 2 h of collection.
Cell culture
We plated 5 × 10 5 PBMCs in 3 wells of a 24-well culture plate (Nunclon, Aarhus, Denmark) in 1 ml sterile tissue culture medium (RPMI 1640; Gibco, Grand Island, NY, USA) containing 5% heat-inactivated bovine serum, 200 mg/dl glucose, and 1 mM sodium pyruvate (Gibco). The cells in the first well were stimulated with 1 mg/ml LPS (Sigma, St. Louis, MO, USA). The cells in the second well were stimulated with 1 mg/ml LPS and treated with additional 225 mg/dl (12.5 mM) glucose. The cells in the third well were stimulated with 1 mg/ml LPS and treated with 12.5 mM mannitol. The culture plate was incubated at 37°C in 5% CO 2 . Supernatants and PBMCs were sampled after 24 h of incubation. The PBMCs were homogenized in 1 ml Trizol Reagent (Invitrogen Corp., Carlsbad, CA, USA). These samples were stored at −−80°C until use.
Measurement of IL-12 levels
The IL-12p40 concentration in the supernatants was measured with a human enzyme-linked immunosorbent assay (ELISA) kit (Becton Dickinson, Franklin Lakes, NJ, USA) according to the manufacturer's instruction. The minimum detectable concentration of this IL-12p40 ELISA kit was 3.9 pg/ml.
Detect IL-12p40 gene expression
Total cellular RNA was extracted from the Trizol reagent with homogenized PBMCs according to the manufacturer's instruction. One microgram RNA was reverse transcribed into cDNA by the SuperScript Choice System for cDNA Synthesis Reagents (Promega Corp., Madison, WI, USA). For the detection of IL-12p40 gene expression, the cDNA was amplified using the following pair of primers: Forward primer 5′-GTG AGC CGT GAT TGT GC-3′ and reverse primer 5′-CTG TGT CTT TTA GAG AGG TGG G-3′. The expression of a housekeeping gene, human acidic ribosomal protein (HuPO), was analyzed for normalizing the amount of cDNA in each sample. The primer pairs used in the polymerase chain reaction (PCR) were: Forward primer 5′-GCT TCC TGG AGG GTG TCC-3′ and reverse primer 5′-GGA CTC GTT TGT ACC CGT TG-3′. The PCR mixture was amplified as follows: Activation step of 7 min at 94ºC, denaturation at 94ºC for 1 min, primer annealing at 62ºC for 30 s, and primer extension at 72ºC for 1 min (28 cycles), followed by a final extension step for 10 min at 72ºC. The 28 PCR cycles were chosen by a 26-38 cycle profile [ Figure 1 ]. The above primers were purchased from Purigo Biotech, Incorporation (Taipei, Taiwan). The PCR products were subjected to gel electrophoresis. Ethidium bromide staining and autography were used to detect two DNA bands. The DNA band of 137 bp corresponded to IL-12p40 cDNA and the other DNA band of 105 bp corresponded to HuPO cDNA.
The PCR products were detected and analyzed on an image analyzer (Scientific Imaging Systems V.3.6.3., Kodak Company, Stamfort, CT, USA). The IL-12p40 mRNA expression was calculated as the ratio of IL-12 p40 amplicons per 10
5 HuPO PCR amplicons.
Statistical analysis
Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) V17.0 for Windows (SPSS, Inc., Chicago, IL, USA). Differences for categorical variables between two groups were compared using the Chi-Square test. Differences in continuous variables of two groups were analyzed by the Mann-Whitney test. Differences in continuous variables of the same patient were analyzed with the Wilcoxon signed ranks test. A value of p < 0.05 was considered statistically significant.
RESULTS
Effect of glucose and mannitol on IL-12 production from stimulated PBMCs
The clinical characteristics in 13 type 2 DM patients and healthy controls are shown in Table 1 . Age in DM patients was higher than that in healthy controls. Stimulated PBMCs of DM patients produced more IL-12 following glucose treatment than those without glucose treatment and with mannitol treatment [ Figure 2] . After 24 h, no significant difference in the IL-12 production was observed among LPS-stimulated PBMCs of controls in the absence and presence of glucose or mannitol.
Effect of glucose and mannitol on IL-12 mRNA expression from stimulated PBMCs Stimulated PBMCs of DM patients expressed more IL-12 mRNA following glucose treatment than those without glucose treatment and with mannitol treatment [ Figure 3 ]. Stimulated PBMCs of controls did not express more IL-12 mRNA following glucose treatment than those without glucose treatment and with mannitol treatment.
DISCUSSION
This is the first study showing hyperglycemia-mediated enhanced IL-12 production by increased gene expression in stimulated PBMCs of type 2 diabetes patients. The increased production of IL-12 was not due to elevated blood osmolarity. The IL-12 protein could be detected in the supernatant of stimulated PBMCs after 24 h of culture. Moreover, the IL-12 protein production and gene expression were higher in the presence of glucose than in the absence of glucose or in the presence of mannitol. These results were in accordance with those of our previous study, which showed that glucose together with LPS might enhance production of the IL-12 protein. [5] IL-12 proteins in the supernatants of cultured cells might also be from apoptosis cells. Hyperglycemic conditions enhanced both mouse and human thymocytes' survival. [10] Thus, increased production of the IL-12 protein was not associated with the release from apoptosis cells.
The level of IL-12 mRNA expression was increased in LPS-stimulated PBMCs of DM patients with additional glucose treatment. IL-12 gene expression is mediated by nuclear factor-kappa B (NF-κB). [11, 12] High glucose has been shown to induce NF-κB activation. [13] It is reasonable to hypothesize that increased IL-12 mRNA after glucose treatment was associated with NF-κB activation. PBMCs of DM patients transform glucose to some metabolites which might enhance IL-12 gene expression. Nonenzymatic glycoxidation of macromolecules ultimately resulting in the formation of advanced glycation endproduct (AGE) is enhanced in the presence of hyperglycemia, and systemic or local oxidant stress. [14] Receptor of AGE has been identified as a central signal transduction receptor mediating long-lasting NF-κB activation in various cell types, including mononuclear phagocytes and vascular endothelium. [15] This indicates that glucose may not directly enhance the IL-12 mRNA expression. The mediator of AGE may also explain the cause why IL-12 gene expression and production did not increase after glucose treatment in healthy controls. Simply, the PBMCs of healthy controls need more time to format AGE because the PBMCs of healthy controls usually are in euglycemia. This hypothesis needs further study for confirmation.
Our study further confirmed that mannitol did not increase more IL-12 gene expression in stimulated PBMCs of DM patients and healthy controls. This result is similar to that of Wen's study which showed that 15 mmol/l mannitol did not influence IL-12 gene expression in mouse macrophage. [6] More studies are needed to determine the influence of osmolarity on cytokine gene expression and production.
IL-12 response from PBMCs was restored in patients who survived severe sepsis. [16] Impaired pre-operative monocyte IL-12 secretion was found in patients who developed fatal postoperative sepsis. [17] These results are similar to those of Stanilova's study, [18] which showed that survivors with severe sepsis produce more IL-12 from LPS-stimulated PBMCs than non-survivors. The main immunological function of IL-12 is to enhance native T lymphocyte differentiation to Th1 cells. Th1 cells secrete interferon-γ that regulates macrophage and natural killer (NK) cell activation, stimulates immunoglobulin secretion by B cells, and enhances Th1 cell differentiation. Thus, increased IL-12 response in patients with severe sepsis may exert a protective effect by increased cellular immunity and phagocytic functions.
Macrovascular complication is important in DM patients. Inflammation is associated with the pathogenesis of coronary atherosclerosis. Circulating IL-12 may provide a mechanistic link between inflammation and Th1-type cytokine production in coronary atherosclerosis. [19] IL-12 also induced T-cell recruitment into the atherosclerotic plaque. [20] Furthermore, functional blockade of endogenous IL-12 by vaccination might result in a significant 68.5% reduction in atherogenesis in mice. Although hyperglycemia might increase IL-12 production in stimulated PBMCs of type 2 diabetes patients, [5] overproduction of IL-12 during sepsis might harm the cardiovascular system. When a gene is induced, the expression of its protein starts with the transcription of mRNA. The mRNA translocates to the rough endoplasmic reticulum (ER). After the protein is synthesized from mRNA by ribosomes and modified to become a matured protein in the ER, it is recruited into ER transport vesicles. The ER transport vesicles are transported from the ER to the trans-Golgi network, and then to constitutive secretory vesicles of the trans-Golgi network. The secretory vesicles of the protein require specific molecules, such as hormones or digestive enzymes, to regulate their exocytosis pathway. IL-12 was significantly produced from PBMCs 24 h after LPS stimulation and was not produced from unstimulated PBMCs. [5] Thus, we can hypothesize that LPS is associated not only with IL-12 gene expression but also with IL-12 secretion. IL-12 protein exocytosis from intracellular space to extracellular space might be triggered by LPS. Intracellular IL-12 protein was digested if cells were not stimulated. In this study, the effect of glucose on IL-12 secretion was not determined because of no detection of intracellular IL-12 protein level. Whether glucose could regulate IL-12 exocytosis is unknown.
Conclusions
The increase in the glucose-mediated IL-12 production in stimulated PBMCs of type 2 DM patients was through an increase in the IL-12 gene expression. Hyperosmolarity did not influence IL-12 gene expression and production in type 2 DM patients. Glucose might act as an enhancer of the LPS-related increase in IL-12 production.
